ArticleMovement disorders clinical practice2021

Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome.

Andrew Billnitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.